Lotus Eye Hospital And Institute Ltd.
NSE: LOTUSEYE · Hospital
Snapshot
Unlock Lotus Eye Hospital And Institute Ltd.'s vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Lotus Eye Hospital and Institute Limited is an Indian healthcare provider specialising in comprehensive eye care services, including refractive surgery, retina, cornea, and glaucoma treatments. The company also operates an eye bank and provides academic training through ophthalmic fellowship and DNB teaching programmes.
Business Model
The company generates revenue by providing specialised ophthalmic surgical and diagnostic services to patients across its network of hospitals. Additionally, it derives income from educational services, including fellowship training and medical teaching programmes.
- Incorporation Year:1997
Growth Outlook
Growth is driven by the increasing demand for specialised eye care services and the expansion of its medical training and fellowship programmes. The company continues to leverage its established reputation in the ophthalmology sector to maintain its market position.
Key Risks
- Regulatory Compliance. The hospital sector is subject to stringent healthcare regulations and licensing requirements that may impact operational costs.
- Competitive Pressure. The company faces intense competition from both large hospital chains and independent eye care clinics in the Indian market.
- Technological Obsolescence. Rapid advancements in ophthalmic surgical technology require continuous capital expenditure to maintain state-of-the-art facilities.
- Talent Retention. The ability to attract and retain highly skilled ophthalmologists and medical staff is critical to maintaining service quality and patient trust.
Price
Start your research today
Unlock AI insights, financials, peers and live data on Lotus Eye Hospital And Institute Ltd. and 5,000+ companies — free.
Key Metrics
REVENUE
₹54 Cr
TTM · standalone
NET PROFIT
₹0.08 Cr
TTM · standalone
EPS
₹0.04
TTM · standalone
RETURN ON EQUITY
0.1%
TTM · standalone
RETURN ON CAPITAL EMPLOYED
1.2%
TTM · standalone
P/E
3064.2x
Q4 FY26 · standalone
EV/EBITDA
58.0x
Q4 FY26 · standalone
EBITDA MARGIN
8.5%
TTM · standalone
NET PROFIT MARGIN
-2.4%
Q4 FY26 · standalone
DEBT TO EQUITY
0.2x
Q4 FY26 · standalone
Peers · Hospital
| Company | Mkt Cap (Cr) | P/E | EV/EBITDA | Rev Gr YoY | EBITDA Mgn | ROE | ROCE | 1Y Return |
|---|---|---|---|---|---|---|---|---|
Lotus Eye Hospital And Institute Ltd.LOTUSEYE | 219 | 3064.25 | 58.01 | 8.4% | 8.5% | 0.1% | 1.2% | +59.7% |
Artemis Medicare Services Ltd.ARTEMISMED | 3,537 | 41.98 | 20.85 | 15.4% | 20.2% | 12.0% | 14.4% | +9.9% |
Shalby Ltd.SHALBY | 1,466 | 51.54 | 13.59 | 5.0% | 14.9% | 3.5% | 8.0% | -16.4% |
Gpt Healthcare Ltd.GPTHEALTH | 980 | 29.86 | 14.13 | 16.1% | 19.1% | 16.7% | 19.2% | -12.4% |
Gujarat KidneyGKSL | 812 | — | — | — | 33.0% | — | — | — |
Hannah JosephHANNAH | 138 | — | — | — | 27.0% | — | — | — |
As of Q4 FY26
Financials
Lotus Eye Hospital And Institute Ltd.
NSE: LOTUSEYE · Hospital
Snapshot
Unlock Lotus Eye Hospital And Institute Ltd.'s vital signs
Growth · Profitability · Valuation · Strength · Conviction
Company Overview
Business
Lotus Eye Hospital and Institute Limited is an Indian healthcare provider specialising in comprehensive eye care services, including refractive surgery, retina, cornea, and glaucoma treatments. The company also operates an eye bank and provides academic training through ophthalmic fellowship and DNB teaching programmes.
Business Model
The company generates revenue by providing specialised ophthalmic surgical and diagnostic services to patients across its network of hospitals. Additionally, it derives income from educational services, including fellowship training and medical teaching programmes.
- Incorporation Year:1997
Growth Outlook
Growth is driven by the increasing demand for specialised eye care services and the expansion of its medical training and fellowship programmes. The company continues to leverage its established reputation in the ophthalmology sector to maintain its market position.
Key Risks
- Regulatory Compliance. The hospital sector is subject to stringent healthcare regulations and licensing requirements that may impact operational costs.
- Competitive Pressure. The company faces intense competition from both large hospital chains and independent eye care clinics in the Indian market.
- Technological Obsolescence. Rapid advancements in ophthalmic surgical technology require continuous capital expenditure to maintain state-of-the-art facilities.
- Talent Retention. The ability to attract and retain highly skilled ophthalmologists and medical staff is critical to maintaining service quality and patient trust.
Price
Loading…
Start your research today
Unlock AI insights, financials, peers and live data on Lotus Eye Hospital And Institute Ltd. and 5,000+ companies — free.
Key Metrics
REVENUE
₹54 Cr
TTM · standalone
NET PROFIT
₹0.08 Cr
TTM · standalone
EPS
₹0.04
TTM · standalone
RETURN ON EQUITY
0.1%
TTM · standalone
RETURN ON CAPITAL EMPLOYED
1.2%
TTM · standalone
P/E
3064.2x
Q4 FY26 · standalone
EV/EBITDA
58.0x
Q4 FY26 · standalone
EBITDA MARGIN
8.5%
TTM · standalone
NET PROFIT MARGIN
-2.4%
Q4 FY26 · standalone
DEBT TO EQUITY
0.2x
Q4 FY26 · standalone
Peers · Hospital
As of Q4 FY26